ALOT News & Events

Reports Q4 revenue $37.5M vs $37.36M last year. Jorik Ittmann, President and Chief Executive Officer of AstroNova, stated, "The second half of fiscal 2026 was a reset period for AstroNova. As we began the year, we recognized that the changes we were making in the business would begin to be realized with a stronger second half. Our focus was on stabilizing the business and ending the year having generated more cash, reduced debt, and raised accountability across both segments. Our Aerospace business delivered a strong performance, with ToughWriter now representing more than 80% of total flight deck printer shipments, positioning us well as aircraft build rates increase."

"We are making solid progress with the improvement in our Product ID segment and are delivering on the potential of the Aerospace segment. As noted previously, a major royalty obligation for Aerospace will expire in the third quarter this year that will provide an annualized contribution to gross profit of approximately $2 million beginning in the fourth quarter. We are encouraged with our progress and believe we are creating greater opportunity for the business," concluded Mr. Ittmann. For fiscal 2027, AstroNova expects mid-single digit revenue growth and expanded adjusted EBITDA margin.

Astro Med trading resumes

AstroNova announced that its Board of Directors has initiated a review and evaluation of strategic alternatives to maximize shareholder value. The Board's review will consider a range of potential strategic, business and financial alternatives, which may include, among other things, a sale of all or part of the Company, a strategic investment, a merger or other business combination, or other strategic or financial alternatives, as well as continuing to execute on the Company's standalone strategic plan. In connection with this review, the Company has engaged Rockefeller Capital Management as its exclusive financial advisor and Foley Hoag LLP as its legal counsel. The Board has not set a timetable for completion of the strategic review and does not intend to provide updates unless and until it is determined that disclosure is appropriate or required by law. There can be no assurance that the strategic review process will result in any transaction or other strategic change.